Evidence map›Paper›PMID 31772560›Full record

ArticleTobacco induced diseases2019

Cigarette smoke exposure induces expression of the pneumococcal erm(B) macrolide resistance gene.

Kgashane Given Matapa, Therese Dix-Peek, Riana Cockeran, Ronald Anderson, Helen C Steel, Charles Feldman

Open access · goldAbstract read
In one paragraph

Article in Tobacco induced diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 80% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Kgashane Given MatapaDepartment of Medical Immunology, University of Pretoria, Pretoria, South Africa.
Therese Dix-PeekClinical Haematology Division, University of the Witwatersrand, Johannesburg, South Africa.
Riana CockeranDepartment of Medical Immunology, University of Pretoria, Pretoria, South Africa.
Ronald AndersonDepartment of Medical Immunology, University of Pretoria, Pretoria, South Africa.
Helen C SteelDepartment of Medical Immunology, University of Pretoria, Pretoria, South Africa.
Charles FeldmanDivision of Pulmonology, University of the Witwatersrand, Johannesburg, South Africa.
University of Pretoria · ZAUniversity of the Witwatersrand · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCigarette smoking is a well-recognized risk factor for development of severe, invasive pneumococcal disease. However, little is known about the direct effects of exposure to cigarette smoke on the virulence mechanisms of the pathogen, particularly in respect of resistance to macrolide antibiotics, which are widely used in the treatment of pneumococcal infection. This study aimed to investigate the effects of exposure to cigarette smoke condensate (CSC, 80 and 160 mg/L) and clarithromycin (2 and 8 mg/L), alone and in combination

methodsFollowing exposure to CSC or clarithromycin, individually and in combination,

resultsAs expected, exposure of both test strains of the pneumococcus to clarithromycin resulted in substantial upregulation of both macrolide resistance genes, which was significantly (p<0.001) augmented by prior exposure to CSC in the case of

conclusionAlthough the possible clinical significance remains to be established, these findings suggest that smoking may impede the efficacy of macrolide-based antimicrobial therapy by accelerating the onset and magnitude of

Indexed as

antibiotic resistancemacrolidespneumococcussmokingstreptococcus pneumoniae

Identifiers

PMID31772560
PMCPMC6876168
OpenAlexW2989922853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.